MEDIPOST has been invited to an international meeting of major investors on global pharmaceuticals and venture investors.

MEDIPOST attended the ‘2015 Stem Cell Meeting on the Mesa’ in San Diego, US on 7~9th October and presented on the clinical trials and global extension plans of its stem cell treatments.

The meeting is an annually held meeting by ARM consisted of investors, patient groups, investigators, academic and big multinational companies, and is acknowledged as the most influential meeting in global high-tech medicine investment.

MEDIPOST presented on ‘CARTISTEM^®’, a knee cartilage loss treatment for degenerative osteoarthritis patients, and development plans for ‘PNEUMOSTEM^®’, a preventive treatment of bronchial pulmonary dysplasia of premature babies.